Successful late conversion to mycophenolate mofetil and prednisone immunosuppression therapy in a renal transplant recipient

الملخص EN

A 35-year old male patient developed elevated transaminases about an year after cadaveric donor renal transplantation maintained on triple immunosuppression therapy.

Azathioprine was discontinued and the liver enzymes normalized.

Three years later, he showed evidence of cyclosporin (CyA) nephrotoxicity as well as sclerosing cholangitis.

The dose of CyA was therefore reduced.

This was followed shortly by deterioration of his renal function and mycophenolate mofetil (MMF) (3 gm daily) was therefore introduced.

He developed intractable diarrhea, which improved on reducing the dose of MMF to 2 gm per day.

Eventually, the patient seemed to stabilize on low dose CyA and prednisone (Pred) along with 2 gm of MMF.

Four months later, the patient discontinued CyA on his own but continued with MMF and Pred.

Over the following two years, his renal functions have remained stable with serum creatinine of around 120 μmol / L, despite the low immunosuppression being administered.